Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis
- 16 March 1991
- journal article
- Published by Elsevier in The Lancet
- Vol. 337 (8742), 627-630
- https://doi.org/10.1016/0140-6736(91)92447-a
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, KenyaThe Lancet, 1990
- Detection of Herpes Simplex Virus DNA in Cutaneous Lesions of Erythema MultiformeJournal of Investigative Dermatology, 1989
- The Association of Tuberculosis and HIV Infection in BurundiAIDS Research and Human Retroviruses, 1989
- Cutaneous manifestations of human immunodeficiency virus in Lusaka, ZambiaJournal of the American Academy of Dermatology, 1988
- Tuberculosis in Patients with the Acquired Immunodeficiency Syndrome: Clinical Features, Response to Therapy, and SurvivalAmerican Review of Respiratory Disease, 1987
- Tuberculosis, Atypical Mycobacteriosis, and the Acquired Immunodeficiency Syndrome Among Haitian and Non-Haitian Patients in South FloridaAnnals of Internal Medicine, 1984
- Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1984
- Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in east Africa third report of fifth investigationTubercle, 1973
- A second international co-operative investigation into thiacetazone side-effects Rashes on two thiacetazone containing regimensTubercle, 1971
- An international co-operative investigation into thiacetazone (thioacetazone) side-effectsTubercle, 1966